TrialThe Journal of clinical endocrinology and metabolism2011

GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide.

Laszlo Hegedüs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.